PARSHALL B LYNNE sold 8.9% of their position (5K shares) of IONIS PHARMACEUTICALS INC on the open market
Open‑market sale worth $381.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/17/2026ACC: 0000874015-26-000172
-5K
Net shares
Net seller
$381.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
5K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−4.47K
Price / share
$76.19
Trade value
$340.26K
% of position
7.9%
4/15/2026
56.34K→51.88K
Common Stock
Direct
Shares
−534.00
Price / share
$76.97
Trade value
$41.10K
% of position
1.0%
4/15/2026
51.88K→51.34K
Total
Net shares
−5K
Net value
-$381.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/15/2026 | S · Sale | −4.47K | $76.19 | $340.26K | 7.9% | 56.34K | 51.88K |
| Common Stock Direct | 4/15/2026 | S · Sale | −534.00 | $76.97 | $41.10K | 1.0% | 51.88K | 51.34K |
| Total | −5K | -$381.37K | ||||||
Derivative Transactions0
No derivative transactions reported